Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Merrimack Pharmaceuticals history
Merrimack Pharmaceuticals company history timeline
Merrimack was founded by a group of scientists from MIT and Harvard University in 2000.
In October 2016, CEO Robert Mulroy resigned and the company announced they would be laying off 20% of its employees.
In January 2017, interim CEO Gary Crocker resigned and the board of directors appointed Richard Peters to be president and CEO. Peters previously worked at Sanofi and was a faculty member at Harvard University.
In January 2017, French pharmaceutical company Ipsen announced they would be purchasing Onivyde from Merrimack for approximately $1 billion.
On November 13, 2018, the statistical programming director Songjiang Wang, received "six months in prison and one year supervised released" after a guilty verdict was handed down to Wang from a United States District Judge in July 2018 for securities fraud and conspiracy to commit securities fraud.
Also on December 20, 2019, the United States Securities and Exchange Commission charged Wang with Insider trading.
Rate Merrimack Pharmaceuticals' efforts to communicate its history to employees.
Merrimack Pharmaceuticals jobs
Do you work at Merrimack Pharmaceuticals?
Is Merrimack Pharmaceuticals' vision a big part of strategic planning?
Merrimack Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Vertex Pharmaceuticals | 1989 | $11.0B | 3,400 | 259 |
| Forest Laboratories | 1954 | $3.6B | 6,200 | - |
| Merck | 1891 | $64.2B | 74,000 | 2,369 |
| Seagen | 1997 | $2.0B | 900 | - |
| Regeneron | 1988 | $14.2B | 9,123 | 424 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 625 |
| Exelixis | 1994 | $2.2B | 484 | 159 |
| AMRI | 1991 | $276.6M | 3,085 | - |
| DURECT | 1998 | $2.0M | 88 | - |
| Aradigm | 1991 | $14.5M | 23 | - |
Merrimack Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of Merrimack Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Merrimack Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Merrimack Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Merrimack Pharmaceuticals. The data presented on this page does not represent the view of Merrimack Pharmaceuticals and its employees or that of Zippia.
Merrimack Pharmaceuticals may also be known as or be related to Merrimack Pharmaceuticals Inc, MERRIMACK PHARMACEUTICALS INC and Merrimack Pharmaceuticals, Inc.